Actions

CD13: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 50: Line 50:


<span style="font-size:90%">'''notes:''' abberent expression is seen in ALL, particularly in B-lineage (and is frequent in regenerating haematogones). In the correct context CD13 expression can indicate MPAL or ETP-ALL (see additional information)  
<span style="font-size:90%">'''notes:''' abberent expression is seen in ALL, particularly in B-lineage (and is frequent in regenerating haematogones). In the correct context CD13 expression can indicate MPAL or ETP-ALL (see additional information)  


{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"

Revision as of 09:33, 27 April 2023



Normal expression and function

CD13 is a cell surface enzyme whose function varies between tissues; its precise function in myeloid cells is unclear. The pattern of expression is similar to other pan-myeloid markers (CD117 and CD33), but with levels generally increasing during maturation (contrasting with CD117 and CD33 whose expression decreases). Maturation of normal myeloid cells may therefore be partly idicated through the relative CD33/13 expression.


Diagnostic role

  • Together with other markers (CD117, CD33 and MPO), CD13 can be used to identify myeloid lineage in acute myeloid leukaemia.
  • CD13 is also expressed by myelomonocytic and monocytic leukaemia cells where a high ratio of CD13/CD33 may have some value in indicating monocytic lineage
  • Expression of CD34 is not required to diagnose AML - CD13 is often absent on more primitive AML cases as well as on those with erythroid or megakaryoblastic differentiation; while aberrant expression in ALL is recognised to occur in around 30% of patients and it is regarded as less specific than CD117 or MPO.


Other relevant information:


Expression is not restricted to myeloid cells, and CD13 is particularly expressed on small intestinal and renal tubular epithelial cells and synaptic membranes from the CNS.



SUMMARY TABLES


CD13 expression: primitive cell types
AML B ALL T ALL ETP ALL MPAL Hgns
freq* freq strg strg freq strg

notes: abberent expression is seen in ALL, particularly in B-lineage (and is frequent in regenerating haematogones). In the correct context CD13 expression can indicate MPAL or ETP-ALL (see additional information)


CD13 expression: mature B cell neoplasms*
CLL MCL FL MZL HCL LPL PCL
rare rare rare rare rare rare rare

notes: overall expression is uncommon in mature B-lymphoproliferative disorders, but may occur at plasma cell differentiation


KEY


1. Colour key: - the likelihood of any individual case expressing this marker, indicated by colour:

Limited studies Rare (<5%) Possible (5-20%) Likely (20-40%) Frequent (40-80%) Expected (80-100%)